Onyx Bridge Wealth Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Onyx Bridge Wealth Group's ABBV Position: Q3 2026 in Review
Onyx Bridge Wealth Group reduced its AbbVie (ABBV) stake by 0.06% in Q3 2026, selling an estimated $1.02K and leaving 6,405 shares worth $1.68M. The position accounts for 0.15% of the portfolio, ranked #123.
Onyx Bridge Wealth Group first reported a position in ABBV in Q2 2021 and has held it in 22 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Onyx Bridge Wealth Group held 6,405 shares of AbbVie worth $1.68M as of Q3 2026.
- Onyx Bridge Wealth Group sold 4 AbbVie shares in Q3 2026, an estimated $1.02K.
- AbbVie made up 0.15% of Onyx Bridge Wealth Group's portfolio in Q3 2026, its #123 holding.
- Onyx Bridge Wealth Group first reported a position in AbbVie in Q2 2021 and has held it in 22 quarters since.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Onyx Bridge Wealth Group's 13F filing for Q3 2026, filed 16 Oct 2026.